中礦資源(002738.SZ):1-2月實現淨利潤4.86億元左右 同比增長約1170.12%
格隆匯3月17日丨中礦資源(002738.SZ)公佈關於公司2022年1-2月主要經營數據的公吿,2022年1月至2月,中礦資源集團股份有限公司生產經營良好,公司新建的2.5萬噸電池級氫氧化鋰和電池級碳酸鋰生產線於2021年11月達產,公司6000噸氟化鋰生產線改擴建完成。由於新建產能均釋放出新的產量,鋰鹽產品價格的上漲,公司盈利能力同比顯著提升。
經公司初步核算,2022年1-2月,公司實現營業收入11.27億元左右,同比增長417.70%左右;實現歸屬於上市公司股東的淨利潤4.86億元左右,同比增長1170.12%左右。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.